Effect of peritoneal dialysis in end-stage renal disease on apixaban pharmacokinetics.

Authors:
Peyro-Saint-Paul L; Bechade C; Cesbron A; Debruyne D; Brionne M and 7 more

Journal:
Nephrol Dial Transplant

Publication Year: 2023

DOI:
10.1093/ndt/gfad087

PMCID:
PMC10387390

PMID:
37169987

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Nephrol Dial Transplant

Abbreviation: Nephrol Dial Transplant

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Transplantation

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A clinical screening algorithm for primary hyperoxaluria type 1 in adults on dialysis.
Ferraro PM; D'Ambrosio V; Gambaro G and 3 more (2024) - Transparency Score: 3/6
A nomogram predicting the histologic activity of lupus nephritis from clinical parameters.
Gao C; Bian X; Wu L and 6 more (2024) - Transparency Score: 3/6
Associations of neutral pH, low-GDP peritoneal dialysis solutions with patient survival, transfer t…
Chen JHC; Johnson DW; Cho Y and 8 more (2024) - Transparency Score: 3/6
Binding and detoxification efficiency of albumin decline after haemodialysis.
Boss K; Waterstradt K; Schnurr K and 7 more (2024) - Transparency Score: 3/6
Contrast-enhanced ultrasonography reveals a lower cortical perfusion and a decreased renal flow res…
Damianaki A; Hendriks-Balk M; Brito W and 7 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST STATEMENT None declared."

Evidence found in paper:

"FUNDING The ApiDP study was funded by the French Health Ministry, PHRC 2018."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025